查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1434729

抗菌药物敏感性测试市场：按产品类型、方法、类型、应用、最终用户划分 - 全球预测 2023-2030

Antimicrobial Susceptibility Testing Market by Product Type (Automated Products, Consumables, Manual Products), Method (Agar Dilution, Disks Diffusion, ETEST), Type, Application, End-User - Global Forecast 2023-2030
出版日期: | 出版商: 360iResearch | 英文 185 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

预计2022年抗菌药物敏感性测试市场规模为36.1亿美元，2023年将达38.1亿美元，2030年预计将达到56.7亿美元，复合年增长率为5.80%。

全球抗菌药物敏感性测试市场

主要市场统计
基准年[2022] 36.1亿美元
预测年份 [2023] 38.1亿美元
预测年份 [2030] 56.7亿美元
复合年增长率（%） 5.80%
抗生素敏感性测试市场-IMG1

抗菌药物敏感性测试 (AST) 确定抗生素和其他抗菌药物对细菌、真菌和病毒等微生物的有效性。此测试方法是指导选择适当的抗生素来治疗感染疾病和监测抗药性微生物菌株出现的重要工具。由于多种因素，该市场正在不断增长，包括感染疾病率的上升、就地检验设施部署的增加以及对快速准确检测抗生素抗药性的需求激增。然而，影响 AST 市场扩张的挑战包括与分子诊断设备和自动化系统等尖端技术相关的高成本，这限制了它们在小规模实验室的采用。此外，新兴国家获得强大的医疗基础设施的机会有限，研发资金不足，并且缺乏该领域的熟练专业人员。影响市场扩张的其他障碍包括影响市场准入和扩张努力的监管政策的区域差异。 。此外，诊断製造商、医疗保健专业人员、研究人员和製药公司等相关人员可以简化流程，同时加速 AST 技术的进步。此外，对感染疾病准确及时诊断的需求不断增长，预计将为市场创造利润丰厚的机会，特别是随着疾病诊断测试技术的技术进步和新基因组鑑定方法的引入。

区域洞察

由于感染疾病发病率上升和医疗基础设施先进，美洲和欧洲是全球抗菌药物敏感性测试市场的重要地区。美国疾病管制与预防中心的美国医疗安全网路 (NHSN) 追踪全国医疗机构的抗菌药物抗药性模式，确保收集高品质的资料，我们正在推动其引入。拉丁美洲在抗菌药物敏感性测试 (AST) 领域取得了重大进展，巴西等国家采用并实施了临床和实验室标准研究所 (CLSI) 制定的指南。这项重要进展将有助于全球对抗抗菌素抗药性的努力，并确保细菌感染疾病的有效治疗选择。此外，欧洲疾病预防与控制中心 (ECDC) 在透过欧洲抗菌药物抗药性监测网路 (EARS-Net) 追踪整个欧洲的抗药性模式方面发挥着至关重要的作用。由于人们对感染疾病的认识不断提高、医疗保健支出不断增加以及抗药性微生物的出现，预计亚太地区 (APAC) 的市场将显着增长。在亚太地区，中国、日本和印度是抗菌药物敏感性测试的主要市场。鑑于这些国家感染疾病负担沉重且人口众多，预计对 AST 产品和服务的需求将会增加。此外，全球政府控制感染疾病的努力以及医疗基础设施投资和资金筹措的增加预计将推动亚太地区的市场成长。

FPNV定位矩阵

FPNV定位矩阵对于评估抗菌药物敏感性测试市场至关重要。我们检视与业务策略和产品满意度相关的关键指标，以对供应商进行全面评估。这种深入的分析使用户能够根据自己的要求做出明智的决策。根据评估，供应商被分为四个成功程度不同的像限：前沿（F）、探路者（P）、利基（N）和重要（V）。

市场占有率分析

市场占有率分析是一种综合工具，可以对抗菌药物敏感性测试市场中供应商的现状进行深入而深入的研究。全面比较和分析供应商在整体收益、基本客群和其他关键指标方面的贡献，以便更好地了解公司的绩效及其在争夺市场占有率时面临的挑战。此外，该分析还提供了对该行业竞争特征的宝贵见解，包括在研究基准年观察到的累积、分散主导地位和合併特征等因素。这种详细程度的提高使供应商能够做出更明智的决策并制定有效的策略，从而在市场上获得竞争优势。

该报告对以下几个方面提供了宝贵的见解：

1-市场渗透率：提供有关主要企业所服务的市场的全面资讯。

2-市场开拓：我们深入研究利润丰厚的新兴市场，并分析它们在成熟细分市场中的渗透率。

3- 市场多元化：提供有关新产品发布、开拓地区、最新发展和投资的详细资讯。

4-竞争力评估与资讯：对主要企业的市场占有率、策略、产品、认证、监管状况、专利状况、製造能力等进行全面评估。

5- 产品开发与创新：提供对未来技术、研发活动和突破性产品开发的见解。

本报告解决了以下关键问题：

1-抗菌药物敏感性测试市场的市场规模和预测是多少？

2-抗菌药物敏感性测试市场预测期内需要考虑投资的产品、细分市场、应用和领域有哪些？

3-抗菌药物敏感性测试市场的技术趋势和法律规范是什么？

4-抗菌药物敏感性测试市场主要供应商的市场占有率为何？

5-进入抗菌药物敏感性检测市场的适当型态和策略手段是什么？

目录

第一章 前言

第二章调查方法

第三章执行摘要

第四章市场概况

第五章市场洞察

  • 市场动态
    • 促进因素
      • 抗菌药物敏感性测试在医疗决策中的重要性
      • 政府打击和预防感染疾病的有利倡议
    • 抑制因素
      • 抗菌药敏套件成本高且缺乏熟练的专业人员
    • 机会
      • 正在进行基于奈米颗粒的抗菌敏感性测试研究
      • 引进新基因组鑑定方法并推出抗菌药物敏感性检测套组
    • 任务
      • 关于产品召回的发生和抗菌药物敏感性测试商业化的严格规定
  • 市场区隔分析
    • 产品类型：用于感染疾病早期诊断和治疗的自动化工具和耗材的进步
    • 方法：发展提高测试准确性的定性 AST 技术
    • 类型：由于对侵袭性真菌感染疾病的认识提高，抗真菌药物敏感性试验取得重大进展
    • 应用：AST 在临床诊断和药物开发中的快速和极端利用
    • 最终用户：AST 在医院和诊断实验室中广泛使用
  • 市场趋势分析
    • 在美洲开发抗菌药物敏感性测试的政府计画和重大研究工作。
    • 专注于抗生素敏感性测试的研发项目，以治疗和诊断亚太地区高度流行的感染疾病
    • 用于抗生素敏感性测试的大量资金以及欧洲、中东和非洲地区监管机构的支持。
  • COVID-19 的累积影响
  • 俄罗斯-乌克兰衝突的累积影响
  • 高通膨的累积效应
  • 波特五力分析
  • 价值炼和关键路径分析
  • 法律规范

第六章抗生素敏感性测试市场：依产品类型

  • 自动化产品
  • 消耗品
  • 手动产品
    • 最低抑菌浓度 (MIC) 试纸条
    • 感光盘
    • 磁化率板

第七章抗菌药物敏感性测试市场：依方法

  • 琼脂稀释
  • 光碟的普及
  • ETEST
  • 基因型鉴定方法
  • 快速自动化方法

第八章抗生素敏感性测试市场：按类型

  • 抗菌药物敏感性测试
  • 抗霉菌药物敏感性试验
  • 驱虫药敏感性试验

第九章抗菌药物敏感性测试市场：依应用分类

  • 临床诊断
  • 药物发现与开发
  • 流行病学

第10章抗菌药物敏感性测试市场：依最终用户分类

  • 合约研究组织
  • 医院和诊断中心
  • 製药和生物技术
  • 研究和学术机构

第十一章美洲抗菌药物敏感性测试市场

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美国

第十二章亚太地区抗菌药物敏感性测试市场

  • 澳洲
  • 中国
  • 印度
  • 印尼
  • 日本
  • 马来西亚
  • 菲律宾
  • 新加坡
  • 韩国
  • 台湾
  • 泰国
  • 越南

第十三章欧洲、中东和非洲抗菌药物敏感性测试市场

  • 丹麦
  • 埃及
  • 芬兰
  • 法国
  • 德国
  • 以色列
  • 义大利
  • 荷兰
  • 奈及利亚
  • 挪威
  • 波兰
  • 卡达
  • 俄罗斯
  • 沙乌地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公国
  • 英国

第14章竞争形势

  • FPNV定位矩阵
  • 市场占有率分析：主要企业
  • 主要企业竞争情境分析
    • 併购
    • 合约、合作和伙伴关係
    • 新产品发布和功能增强
    • 投资、资金筹措
    • 奖项/奖励/扩展

第15章竞争产品组合

  • 主要公司简介
    • Accelerate Diagnostics, Inc.
    • Alifax Srl
    • Becton, Dickinson and Company
    • Bio-Rad Laboratories, Inc.
    • BIOANALYSE Tﾄｱbbi Malz. San. ve Tic. Ltd. Sti.
    • BioMerieux SA
    • Biosafe Ltd.
    • Bruker Corporation
    • Creative Diagnostics
    • Danaher Corporation
    • ELITech Group SAS
    • Erba Lachema sro
    • Eurofins Scientific SE
    • F. Hoffmann-La Roche AG
    • Genefluidics, Inc.
    • Himedia Laboratories Private Limited
    • INTEGRA Biosciences AG
    • Laboratorios Conda, SA
    • Launch Diagnostics Limited
    • Leading Biology, Inc.
    • Liofilchem Srl
    • Mast Group Ltd.
    • MP Biomedicals, LLC
    • Pfizer Inc.
    • Qiagen NV
    • QuantaMatrix Inc.
    • Rapid Test Methods Ltd.
    • Resistell AG
    • Synoptics Group
    • Thermo Fisher Scientific Inc.
    • Zhuhai DL Biotech Co., Ltd.
  • 主要产品系列

第十六章附录

  • 讨论指南
  • 关于许可证和定价
Product Code: MRR-464C422F4BF4

[185 Pages Report] The Antimicrobial Susceptibility Testing Market size was estimated at USD 3.61 billion in 2022 and expected to reach USD 3.81 billion in 2023, at a CAGR 5.80% to reach USD 5.67 billion by 2030.

Global Antimicrobial Susceptibility Testing Market

KEY MARKET STATISTICS
Base Year [2022] USD 3.61 billion
Estimated Year [2023] USD 3.81 billion
Forecast Year [2030] USD 5.67 billion
CAGR (%) 5.80%
Antimicrobial Susceptibility Testing Market - IMG1

Antimicrobial susceptibility testing (AST) determines the effectiveness of antibiotics or other antimicrobial drugs against microorganisms such as bacteria, fungi, and viruses. This testing method is an essential tool for guiding the selection of appropriate antibiotics used in treating infectious diseases and monitoring the emergence of drug-resistant strains of microorganisms. The market is experiencing growth due to various factors, including the rising incidence of infectious disorders, the growing adoption of point-of-care testing facilities, and the surging demand for prompt and precise detection of antibiotic resistance. However, challenges affecting the expansion of the AST market comprise high costs associated with advanced technologies such as molecular diagnostics instruments or automated systems, limiting their adoption by small-scale laboratories. In addition, limited access to robust healthcare infrastructure in developing countries, insufficient funding for research and development (R&D), lack of skilled professionals in the field, and variation in regulatory policies among different regions affecting market entry or expansion efforts are the additional obstacles affecting the expansion of the market. Additionally building partnerships between industry stakeholders such as diagnostic manufacturers, healthcare providers researchers and pharmaceutical companies can streamline processes while driving advancements in AST technologies. Moreover, the increasing demand for accurate and timely diagnosis of infectious diseases is expected to create lucrative opportunities for the market, particularly with the technological advancement in disease diagnosis testing techniques and the introduction of new genomic identification methods.

Regional Insights

The Americas and Europe are significant regions in the global antimicrobial susceptibility testing market due to the rise in infectious diseases and advanced healthcare infrastructure. The Centers for Disease Control and Prevention's National Healthcare Safety Network (NHSN), which tracks antimicrobial resistance patterns in nationwide healthcare facilities, promotes AST adoption while ensuring high-quality data collection. In Latin America, significant progress is observed in the field of antimicrobial susceptibility testing (AST), with countries such as Brazil adopting and executing guidelines established by the Clinical & Laboratory Standards Institute (CLSI). This crucial development contributes to the global efforts in combating antimicrobial resistance, thereby ensuring effective treatment options for bacterial infections. Furthermore, the European Centre for Disease Prevention and Control (ECDC) plays a pivotal role in tracking resistance patterns across Europe through its European Antimicrobial Resistance Surveillance Network (EARS-Net). The Asia-Pacific (APAC) is expected to experience substantial growth in the market due to rising awareness about infectious diseases, increasing healthcare expenditure, and emerging drug-resistant microorganisms. China, Japan, and India are the major markets for antimicrobial susceptibility testing within the Asia-Pacific. These nations have a high burden of infectious diseases and a large population, which is expected to drive the demand for AST products and services. Moreover, government initiatives worldwide to control infectious diseases and rising investments & funding in healthcare infrastructure are expected to bolster the market growth in the APAC.

FPNV Positioning Matrix

The FPNV Positioning Matrix is pivotal in evaluating the Antimicrobial Susceptibility Testing Market. It offers a comprehensive assessment of vendors, examining key metrics related to Business Strategy and Product Satisfaction. This in-depth analysis empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital (V).

Market Share Analysis

The Market Share Analysis is a comprehensive tool that provides an insightful and in-depth examination of the current state of vendors in the Antimicrobial Susceptibility Testing Market. By meticulously comparing and analyzing vendor contributions in terms of overall revenue, customer base, and other key metrics, we can offer companies a greater understanding of their performance and the challenges they face when competing for market share. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With this expanded level of detail, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.

Key Company Profiles

The report delves into recent significant developments in the Antimicrobial Susceptibility Testing Market, highlighting leading vendors and their innovative profiles. These include Accelerate Diagnostics, Inc., Alifax S.r.l., Becton, Dickinson and Company, Bio-Rad Laboratories, Inc., BIOANALYSE Tıbbi Malz. San. ve Tic. Ltd. Sti., BioMerieux SA, Biosafe Ltd., Bruker Corporation, Creative Diagnostics, Danaher Corporation, ELITech Group SAS, Erba Lachema s.r.o., Eurofins Scientific SE, F. Hoffmann-La Roche AG, Genefluidics, Inc., Himedia Laboratories Private Limited, INTEGRA Biosciences AG, Laboratorios Conda, S.A., Launch Diagnostics Limited, Leading Biology, Inc., Liofilchem S.r.l., Mast Group Ltd., MP Biomedicals, LLC, Pfizer Inc., Qiagen N.V., QuantaMatrix Inc., Rapid Test Methods Ltd., Resistell AG, Synoptics Group, Thermo Fisher Scientific Inc., and Zhuhai DL Biotech Co., Ltd..

Market Segmentation & Coverage

This research report categorizes the Antimicrobial Susceptibility Testing Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Product Type
    • Automated Products
    • Consumables
    • Manual Products
      • Minimum Inhibitory Concentration (MIC) Strips
      • Susceptibility Discs
      • Susceptibility Plates
  • Method
    • Agar Dilution
    • Disks Diffusion
    • ETEST
    • Genotyping Methods
    • Rapid Automation Method
  • Type
    • Antibacterial Susceptibility Testing
    • Antifungal Susceptibility Testing
    • Antiparasitic Susceptibility Testing
  • Application
    • Clinical Diagnostics
    • Drug Discovery & Development
    • Epidemiology
  • End-User
    • Contract Research Organizations
    • Hospital & Diagnostic Centers
    • Pharmaceutical & Biotechnology
    • Research & Academic Institutes
  • Region
    • Americas
      • Argentina
      • Brazil
      • Canada
      • Mexico
      • United States
        • California
        • Florida
        • Illinois
        • New York
        • Ohio
        • Pennsylvania
        • Texas
    • Asia-Pacific
      • Australia
      • China
      • India
      • Indonesia
      • Japan
      • Malaysia
      • Philippines
      • Singapore
      • South Korea
      • Taiwan
      • Thailand
      • Vietnam
    • Europe, Middle East & Africa
      • Denmark
      • Egypt
      • Finland
      • France
      • Germany
      • Israel
      • Italy
      • Netherlands
      • Nigeria
      • Norway
      • Poland
      • Qatar
      • Russia
      • Saudi Arabia
      • South Africa
      • Spain
      • Sweden
      • Switzerland
      • Turkey
      • United Arab Emirates
      • United Kingdom

The report offers valuable insights on the following aspects:

1. Market Penetration: It presents comprehensive information on the market provided by key players.

2. Market Development: It delves deep into lucrative emerging markets and analyzes the penetration across mature market segments.

3. Market Diversification: It provides detailed information on new product launches, untapped geographic regions, recent developments, and investments.

4. Competitive Assessment & Intelligence: It conducts an exhaustive assessment of market shares, strategies, products, certifications, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players.

5. Product Development & Innovation: It offers intelligent insights on future technologies, R&D activities, and breakthrough product developments.

The report addresses key questions such as:

1. What is the market size and forecast of the Antimicrobial Susceptibility Testing Market?

2. Which products, segments, applications, and areas should one consider investing in over the forecast period in the Antimicrobial Susceptibility Testing Market?

3. What are the technology trends and regulatory frameworks in the Antimicrobial Susceptibility Testing Market?

4. What is the market share of the leading vendors in the Antimicrobial Susceptibility Testing Market?

5. Which modes and strategic moves are suitable for entering the Antimicrobial Susceptibility Testing Market?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Limitations
  • 1.7. Assumptions
  • 1.8. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

  • 4.1. Introduction
  • 4.2. Antimicrobial Susceptibility Testing Market, by Region

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Importance of antimicrobial susceptibility testing in medical decision-making
      • 5.1.1.2. Favorable government initiatives aiming to combat and prevent infectious diseases
    • 5.1.2. Restraints
      • 5.1.2.1. High cost of antimicrobial susceptibility kits and lack of skilled professionals
    • 5.1.3. Opportunities
      • 5.1.3.1. Ongoing research on nanoparticles-based antimicrobial susceptibility testing
      • 5.1.3.2. Introduction of new genomic identification methods and launch of antimicrobial susceptibility test kits
    • 5.1.4. Challenges
      • 5.1.4.1. Incidence of product recalls and strict regulations regarding antimicrobial susceptibility testing commercialization
  • 5.2. Market Segmentation Analysis
    • 5.2.1. Product Type: Advancement in the automated tools and consumables for early diagnosing and treatment of the infectious diseases
    • 5.2.2. Method: Development of qualitative AST techniques with increased accuracy of the tests
    • 5.2.3. Type: Significant advancements in antifungal susceptibility testing due to heightened awareness of invasive fungal infections
    • 5.2.4. Application: Rapid and extreme utilization of the AST in clinical diagnostics and drug discovery and development
    • 5.2.5. End-User: Extensive use of AST in hospitals and diagnostic laboratories
  • 5.3. Market Trend Analysis
    • 5.3.1. Government programs and significant research activities to develop antimicrobial susceptibility tests in the Americas.
    • 5.3.2. Emphasis on the antibiotic susceptibility testing research and development programmes to treat and diagnose highly prevalent communicable diseases in APAC
    • 5.3.3. Significant funding for antibiotic susceptibility testing and support from regulatory agencies in the EMEA region.
  • 5.4. Cumulative Impact of COVID-19
  • 5.5. Cumulative Impact of Russia-Ukraine Conflict
  • 5.6. Cumulative Impact of High Inflation
  • 5.7. Porter's Five Forces Analysis
    • 5.7.1. Threat of New Entrants
    • 5.7.2. Threat of Substitutes
    • 5.7.3. Bargaining Power of Customers
    • 5.7.4. Bargaining Power of Suppliers
    • 5.7.5. Industry Rivalry
  • 5.8. Value Chain & Critical Path Analysis
  • 5.9. Regulatory Framework

6. Antimicrobial Susceptibility Testing Market, by Product Type

  • 6.1. Introduction
  • 6.2. Automated Products
  • 6.3. Consumables
  • 6.4. Manual Products
    • 6.5.1. Minimum Inhibitory Concentration (MIC) Strips
    • 6.5.2. Susceptibility Discs
    • 6.5.3. Susceptibility Plates

7. Antimicrobial Susceptibility Testing Market, by Method

  • 7.1. Introduction
  • 7.2. Agar Dilution
  • 7.3. Disks Diffusion
  • 7.4. ETEST
  • 7.5. Genotyping Methods
  • 7.6. Rapid Automation Method

8. Antimicrobial Susceptibility Testing Market, by Type

  • 8.1. Introduction
  • 8.2. Antibacterial Susceptibility Testing
  • 8.3. Antifungal Susceptibility Testing
  • 8.4. Antiparasitic Susceptibility Testing

9. Antimicrobial Susceptibility Testing Market, by Application

  • 9.1. Introduction
  • 9.2. Clinical Diagnostics
  • 9.3. Drug Discovery & Development
  • 9.4. Epidemiology

10. Antimicrobial Susceptibility Testing Market, by End-User

  • 10.1. Introduction
  • 10.2. Contract Research Organizations
  • 10.3. Hospital & Diagnostic Centers
  • 10.4. Pharmaceutical & Biotechnology
  • 10.5. Research & Academic Institutes

11. Americas Antimicrobial Susceptibility Testing Market

  • 11.1. Introduction
  • 11.2. Argentina
  • 11.3. Brazil
  • 11.4. Canada
  • 11.5. Mexico
  • 11.6. United States

12. Asia-Pacific Antimicrobial Susceptibility Testing Market

  • 12.1. Introduction
  • 12.2. Australia
  • 12.3. China
  • 12.4. India
  • 12.5. Indonesia
  • 12.6. Japan
  • 12.7. Malaysia
  • 12.8. Philippines
  • 12.9. Singapore
  • 12.10. South Korea
  • 12.11. Taiwan
  • 12.12. Thailand
  • 12.13. Vietnam

13. Europe, Middle East & Africa Antimicrobial Susceptibility Testing Market

  • 13.1. Introduction
  • 13.2. Denmark
  • 13.3. Egypt
  • 13.4. Finland
  • 13.5. France
  • 13.6. Germany
  • 13.7. Israel
  • 13.8. Italy
  • 13.9. Netherlands
  • 13.10. Nigeria
  • 13.11. Norway
  • 13.12. Poland
  • 13.13. Qatar
  • 13.14. Russia
  • 13.15. Saudi Arabia
  • 13.16. South Africa
  • 13.17. Spain
  • 13.18. Sweden
  • 13.19. Switzerland
  • 13.20. Turkey
  • 13.21. United Arab Emirates
  • 13.22. United Kingdom

14. Competitive Landscape

  • 14.1. FPNV Positioning Matrix
  • 14.2. Market Share Analysis, By Key Player
  • 14.3. Competitive Scenario Analysis, By Key Player
    • 14.3.1. Merger & Acquisition
      • 14.3.1.1. Bio-Rad Acquires Curiosity Diagnostics
    • 14.3.2. Agreement, Collaboration, & Partnership
      • 14.3.2.1. JMI Laboratories and bioMerieux Enter Antimicrobial Resistance Diagnostics Partnership
      • 14.3.2.2. FASTinov Collaborates With Beckman Coulter Life Sciences To Bring Ultra-Rapid 2h-AST Disruptive Technology To Clinical Microbiology Laboratories
      • 14.3.2.3. BD Enters Commercial Collaboration With Accelerate Diagnostics
    • 14.3.3. New Product Launch & Enhancement
      • 14.3.3.1. Creative Diagnostics Announces New Antimicrobial Susceptibility Testing Services
      • 14.3.3.2. Sysmex Launches World's First Point-of-Care Testing System in Europe to Detect Antimicrobial Susceptibility in Just 30 Minutes
    • 14.3.4. Investment & Funding
      • 14.3.4.1. Strathclyde spin-out Microplate dx secures GBP 2.5 million in funding
      • 14.3.4.2. Pattern Bioscience Secures USD 28.7 Million in Series C Financing
      • 14.3.4.3. Resistell raises CHF 8.5 million to complete clinical trials for antibiotic susceptibility testing
      • 14.3.4.4. Avails Medical, A Developer 0f Automated and Fully Electrical Antibiotic Susceptibility Testing (East) has Announced the Transition to The Next Phase of Its Carb-X Grant.
    • 14.3.5. Award, Recognition, & Expansion
      • 14.3.5.1. Gradientech Welcomes Investment From Commercial Partner
      • 14.3.5.2. bioMerieux's Submits Vitek Reveal to FDA for Clearance
      • 14.3.5.3. Selux Diagnostics Secures FDA Approval For Its Rapid Antibiotic Susceptibility Test
      • 14.3.5.4. FDA clears rapid antibiotic susceptibility test

15. Competitive Portfolio

  • 15.1. Key Company Profiles
    • 15.1.1. Accelerate Diagnostics, Inc.
    • 15.1.2. Alifax S.r.l.
    • 15.1.3. Becton, Dickinson and Company
    • 15.1.4. Bio-Rad Laboratories, Inc.
    • 15.1.5. BIOANALYSE Tıbbi Malz. San. ve Tic. Ltd. Sti.
    • 15.1.6. BioMerieux SA
    • 15.1.7. Biosafe Ltd.
    • 15.1.8. Bruker Corporation
    • 15.1.9. Creative Diagnostics
    • 15.1.10. Danaher Corporation
    • 15.1.11. ELITech Group SAS
    • 15.1.12. Erba Lachema s.r.o.
    • 15.1.13. Eurofins Scientific SE
    • 15.1.14. F. Hoffmann-La Roche AG
    • 15.1.15. Genefluidics, Inc.
    • 15.1.16. Himedia Laboratories Private Limited
    • 15.1.17. INTEGRA Biosciences AG
    • 15.1.18. Laboratorios Conda, S.A.
    • 15.1.19. Launch Diagnostics Limited
    • 15.1.20. Leading Biology, Inc.
    • 15.1.21. Liofilchem S.r.l.
    • 15.1.22. Mast Group Ltd.
    • 15.1.23. MP Biomedicals, LLC
    • 15.1.24. Pfizer Inc.
    • 15.1.25. Qiagen N.V.
    • 15.1.26. QuantaMatrix Inc.
    • 15.1.27. Rapid Test Methods Ltd.
    • 15.1.28. Resistell AG
    • 15.1.29. Synoptics Group
    • 15.1.30. Thermo Fisher Scientific Inc.
    • 15.1.31. Zhuhai DL Biotech Co., Ltd.
  • 15.2. Key Product Portfolio

16. Appendix

  • 16.1. Discussion Guide
  • 16.2. License & Pricing

LIST OF FIGURES

  • FIGURE 1. ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET RESEARCH PROCESS
  • FIGURE 2. ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, 2022 VS 2030
  • FIGURE 3. ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY REGION, 2022 VS 2030 (%)
  • FIGURE 5. ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY REGION, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 6. ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET DYNAMICS
  • FIGURE 7. ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY PRODUCT TYPE, 2022 VS 2030 (%)
  • FIGURE 8. ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY PRODUCT TYPE, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 9. ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY METHOD, 2022 VS 2030 (%)
  • FIGURE 10. ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY METHOD, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 11. ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY TYPE, 2022 VS 2030 (%)
  • FIGURE 12. ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY TYPE, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 13. ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY APPLICATION, 2022 VS 2030 (%)
  • FIGURE 14. ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY APPLICATION, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 15. ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY END-USER, 2022 VS 2030 (%)
  • FIGURE 16. ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY END-USER, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 17. AMERICAS ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY COUNTRY, 2022 VS 2030 (%)
  • FIGURE 18. AMERICAS ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY COUNTRY, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 19. UNITED STATES ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY STATE, 2022 VS 2030 (%)
  • FIGURE 20. UNITED STATES ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY STATE, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 21. ASIA-PACIFIC ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY COUNTRY, 2022 VS 2030 (%)
  • FIGURE 22. ASIA-PACIFIC ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY COUNTRY, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 23. EUROPE, MIDDLE EAST & AFRICA ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY COUNTRY, 2022 VS 2030 (%)
  • FIGURE 24. EUROPE, MIDDLE EAST & AFRICA ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY COUNTRY, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 25. ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET, FPNV POSITIONING MATRIX, 2022
  • FIGURE 26. ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SHARE, BY KEY PLAYER, 2022

LIST OF TABLES

  • TABLE 1. ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2022
  • TABLE 3. ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 6. ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY AUTOMATED PRODUCTS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 7. ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY CONSUMABLES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 8. ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY MANUAL PRODUCTS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY MANUAL PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 10. ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY MINIMUM INHIBITORY CONCENTRATION (MIC) STRIPS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 11. ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY SUSCEPTIBILITY DISCS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 12. ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY SUSCEPTIBILITY PLATES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 13. ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 14. ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY AGAR DILUTION, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 15. ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY DISKS DIFFUSION, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 16. ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY ETEST, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 17. ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY GENOTYPING METHODS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 18. ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY RAPID AUTOMATION METHOD, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 19. ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 20. ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY ANTIBACTERIAL SUSCEPTIBILITY TESTING, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 21. ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY ANTIFUNGAL SUSCEPTIBILITY TESTING, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 22. ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY ANTIPARASITIC SUSCEPTIBILITY TESTING, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 23. ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 24. ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY CLINICAL DIAGNOSTICS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 25. ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY DRUG DISCOVERY & DEVELOPMENT, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 26. ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY EPIDEMIOLOGY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 27. ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 28. ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 29. ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY HOSPITAL & DIAGNOSTIC CENTERS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 30. ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY PHARMACEUTICAL & BIOTECHNOLOGY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 31. ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY RESEARCH & ACADEMIC INSTITUTES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 32. AMERICAS ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 33. AMERICAS ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY MANUAL PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 34. AMERICAS ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 35. AMERICAS ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 36. AMERICAS ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 37. AMERICAS ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 38. AMERICAS ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 39. ARGENTINA ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 40. ARGENTINA ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY MANUAL PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 41. ARGENTINA ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 42. ARGENTINA ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 43. ARGENTINA ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 44. ARGENTINA ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 45. BRAZIL ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 46. BRAZIL ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY MANUAL PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 47. BRAZIL ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 48. BRAZIL ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 49. BRAZIL ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 50. BRAZIL ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 51. CANADA ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 52. CANADA ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY MANUAL PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 53. CANADA ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 54. CANADA ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 55. CANADA ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 56. CANADA ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 57. MEXICO ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 58. MEXICO ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY MANUAL PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 59. MEXICO ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 60. MEXICO ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 61. MEXICO ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 62. MEXICO ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 63. UNITED STATES ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 64. UNITED STATES ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY MANUAL PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 65. UNITED STATES ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 66. UNITED STATES ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 67. UNITED STATES ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 68. UNITED STATES ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 69. UNITED STATES ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 70. ASIA-PACIFIC ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 71. ASIA-PACIFIC ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY MANUAL PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 72. ASIA-PACIFIC ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 73. ASIA-PACIFIC ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 74. ASIA-PACIFIC ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 75. ASIA-PACIFIC ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 76. ASIA-PACIFIC ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 77. AUSTRALIA ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 78. AUSTRALIA ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY MANUAL PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 79. AUSTRALIA ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 80. AUSTRALIA ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 81. AUSTRALIA ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 82. AUSTRALIA ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 83. CHINA ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 84. CHINA ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY MANUAL PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 85. CHINA ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 86. CHINA ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 87. CHINA ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 88. CHINA ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 89. INDIA ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 90. INDIA ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY MANUAL PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 91. INDIA ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 92. INDIA ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 93. INDIA ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 94. INDIA ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 95. INDONESIA ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 96. INDONESIA ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY MANUAL PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 97. INDONESIA ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 98. INDONESIA ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 99. INDONESIA ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 100. INDONESIA ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 101. JAPAN ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 102. JAPAN ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY MANUAL PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 103. JAPAN ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 104. JAPAN ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 105. JAPAN ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 106. JAPAN ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 107. MALAYSIA ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 108. MALAYSIA ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY MANUAL PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 109. MALAYSIA ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 110. MALAYSIA ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 111. MALAYSIA ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 112. MALAYSIA ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 113. PHILIPPINES ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 114. PHILIPPINES ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY MANUAL PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 115. PHILIPPINES ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 116. PHILIPPINES ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 117. PHILIPPINES ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 118. PHILIPPINES ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 119. SINGAPORE ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 120. SINGAPORE ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY MANUAL PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 121. SINGAPORE ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 122. SINGAPORE ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 123. SINGAPORE ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 124. SINGAPORE ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 125. SOUTH KOREA ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 126. SOUTH KOREA ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY MANUAL PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 127. SOUTH KOREA ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 128. SOUTH KOREA ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 129. SOUTH KOREA ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 130. SOUTH KOREA ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 131. TAIWAN ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 132. TAIWAN ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY MANUAL PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 133. TAIWAN ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 134. TAIWAN ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 135. TAIWAN ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 136. TAIWAN ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 137. THAILAND ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 138. THAILAND ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY MANUAL PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 139. THAILAND ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 140. THAILAND ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 141. THAILAND ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 142. THAILAND ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 143. VIETNAM ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 144. VIETNAM ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY MANUAL PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 145. VIETNAM ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 146. VIETNAM ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 147. VIETNAM ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 148. VIETNAM ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 149. EUROPE, MIDDLE EAST & AFRICA ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 150. EUROPE, MIDDLE EAST & AFRICA ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY MANUAL PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 151. EUROPE, MIDDLE EAST & AFRICA ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 152. EUROPE, MIDDLE EAST & AFRICA ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 153. EUROPE, MIDDLE EAST & AFRICA ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 154. EUROPE, MIDDLE EAST & AFRICA ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 155. EUROPE, MIDDLE EAST & AFRICA ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 156. DENMARK ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 157. DENMARK ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY MANUAL PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 158. DENMARK ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 159. DENMARK ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 160. DENMARK ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 161. DENMARK ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 162. EGYPT ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 163. EGYPT ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY MANUAL PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 164. EGYPT ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 165. EGYPT ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 166. EGYPT ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 167. EGYPT ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 168. FINLAND ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 169. FINLAND ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY MANUAL PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 170. FINLAND ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 171. FINLAND ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 172. FINLAND ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 173. FINLAND ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 174. FRANCE ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 175. FRANCE ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY MANUAL PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 176. FRANCE ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 177. FRANCE ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 178. FRANCE ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 179. FRANCE ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 180. GERMANY ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 181. GERMANY ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY MANUAL PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 182. GERMANY ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 183. GERMANY ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 184. GERMANY ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 185. GERMANY ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 186. ISRAEL ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 187. ISRAEL ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY MANUAL PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 188. ISRAEL ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 189. ISRAEL ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 190. ISRAEL ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 191. ISRAEL ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 192. ITALY ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 193. ITALY ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY MANUAL PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 194. ITALY ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 195. ITALY ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 196. ITALY ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 197. ITALY ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 198. NETHERLANDS ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 199. NETHERLANDS ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY MANUAL PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 200. NETHERLANDS ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 201. NETHERLANDS ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 202. NETHERLANDS ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 203. NETHERLANDS ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 204. NIGERIA ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 205. NIGERIA ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY MANUAL PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 206. NIGERIA ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 207. NIGERIA ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 208. NIGERIA ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 209. NIGERIA ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 210. NORWAY ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 211. NORWAY ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY MANUAL PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 212. NORWAY ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 213. NORWAY ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 214. NORWAY ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 215. NORWAY ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 216. POLAND ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 217. POLAND ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY MANUAL PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 218. POLAND ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 219. POLAND ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 220. POLAND ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 221. POLAND ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 222. QATAR ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 223. QATAR ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY MANUAL PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 224. QATAR ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 225. QATAR ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 226. QATAR ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 227. QATAR ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 228. RUSSIA ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 229. RUSSIA ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY MANUAL PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 230. RUSSIA ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 231. RUSSIA ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 232. RUSSIA ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 233. RUSSIA ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 234. SAUDI ARABIA ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 235. SAUDI ARABIA ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY MANUAL PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 236. SAUDI ARABIA ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 237. SAUDI ARABIA ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 238. SAUDI ARABIA ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 239. SAUDI ARABIA ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 240. SOUTH AFRICA ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 241. SOUTH AFRICA ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY MANUAL PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 242. SOUTH AFRICA ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 243. SOUTH AFRICA ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 244. SOUTH AFRICA ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 245. SOUTH AFRICA ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 246. SPAIN ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 247. SPAIN ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY MANUAL PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 248. SPAIN ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 249. SPAIN ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 250. SPAIN ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 251. SPAIN ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 252. SWEDEN ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 253. SWEDEN ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY MANUAL PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 254. SWEDEN ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 255. SWEDEN ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 256. SWEDEN ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 257. SWEDEN ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 258. SWITZERLAND ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 259. SWITZERLAND ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY MANUAL PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 260. SWITZERLAND ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 261. SWITZERLAND ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 262. SWITZERLAND ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 263. SWITZERLAND ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 264. TURKEY ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 265. TURKEY ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY MANUAL PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 266. TURKEY ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 267. TURKEY ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 268. TURKEY ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 269. TURKEY ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 270. UNITED ARAB EMIRATES ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 271. UNITED ARAB EMIRATES ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY MANUAL PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 272. UNITED ARAB EMIRATES ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 273. UNITED ARAB EMIRATES ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 274. UNITED ARAB EMIRATES ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 275. UNITED ARAB EMIRATES ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 276. UNITED KINGDOM ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 277. UNITED KINGDOM ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY MANUAL PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 278. UNITED KINGDOM ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 279. UNITED KINGDOM ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 280. UNITED KINGDOM ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 281. UNITED KINGDOM ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 282. ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET, FPNV POSITIONING MATRIX, 2022
  • TABLE 283. ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SHARE, BY KEY PLAYER, 2022
  • TABLE 284. ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET LICENSE & PRICING